Skip to main content

Advertisement

SpringerLink
Log in

Large intestine

Remission of lymphocytic colitis with budesonide

  • News & Views
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

Few randomized, controlled trials have investigated the efficacy of pharmacological treatment for lymphocytic colitis. Data from a new randomized, placebo-controlled trial have demonstrated the efficacy of budesonide in inducing remission of this disease; this study is an important contribution to this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tysk, C., Bohr, J., Nyhlin, N., Wickbom, A. & Eriksson, S. Diagnosis and management of microscopic colitis. World J. Gastroenterol. 14, 7280–7288 (2008).

    Article  Google Scholar 

  2. Chande, N., McDonald, J. W. & Macdonald, J. K. Interventions for treating lymphocytic colitis. Cochrane Database of Systematic Reviews Issue 2 Art. No.: CD006096. doi: 10.1002/14651858.CD006096.pub3 (2008).

    Google Scholar 

  3. Calabrese, C. et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J. Gastroenterol. Hepatol. 22, 809–814 (2007).

    Article  CAS  Google Scholar 

  4. Miehlke, S. et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 136, 2092–2100 (2009).

    Article  CAS  Google Scholar 

  5. Baert, F. et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 122, 20–25 (2002).

    Article  CAS  Google Scholar 

  6. Bonderup, O. K. et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 52, 248–251 (2003).

    Article  CAS  Google Scholar 

  7. Miehlke, S. et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 123, 978–984 (2002).

    Article  CAS  Google Scholar 

  8. Bonderup, O. K., Hansen, J. B., Teglbjaerg, P. S., Christensen, L. A. & Fallingborg, J. F. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 58, 68–72 (2009).

    Article  CAS  Google Scholar 

  9. Miehlke, S. et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 135, 1510–1516 (2008).

    Article  CAS  Google Scholar 

  10. Hjortswang, H. et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm. Bowel Dis. doi:10.1002/ibd.20977.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. C. Tysk, Department of Medicine, Division of Gastroenterology, Örebro University Hospital, 70185 Örebro, Sweden curt.tysk@orebroll.se

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology, Örebro University Hospital, Örebro, Sweden

    Curt Tysk

Authors
  1. Curt Tysk
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tysk, C. Remission of lymphocytic colitis with budesonide. Nat Rev Gastroenterol Hepatol 6, 506–507 (2009). https://doi.org/10.1038/nrgastro.2009.139

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2009.139

  • Springer Nature Limited

This article is cited by

Search

Navigation